The plant lignan secoisolariciresinol diglycoside (SDG) from flaxseed may be antitumorigenic due to its estrogenic and antiestrogenic effects, anti-oxidative effects, antiproliferative and anti-aromatase effects. Review of studies showing anticarcinogenic
With patients often facing grim prognoses, and insurers relatively powerless to negotiate prices or deny coverage, the cost of treatments have little impact on demand.
A high intake of plant lignans could reduce the risk of breast cancer for pre-menopausal women by 78 per cent, says new research from Germany that adds significantly to the current body of science. Plant lignans, from sources such as flax seed, whole grai
Triterpinoids in apple peels have potent anti-proliferative activities against human liver, colon and breast cancer cells," said Rui Hai Liu, Cornell associate professor of food science.
Emergingresearch in the fields of radiology, drug therapeutics, and vaccine development has great potential to change breast cancer treatment & prevention.
While acknowledging that disadvantaged populations tend not to reap the benefits of regular mammograms and self-exams as much as others, Winer and Eng-Wong said most American women have been duly educated about their value.
Peter M. Ravdin, MD, PhD, reviews the latest update of the ASCO Clinical Practice Guidelines on bisphosphonate use and bone health in women with breast cancer.
Women who develop breast cancer because they carry defective genes are no less likely to survive over the long term than other breast cancer patients, Canadian and Israeli researchers said on Wednesday.
Women Health Programs is a purveyor of women health care medication ranging from birth control to skin and hair care. We deal in a large variety of FDA approved and safe drugs which are known to improve the quality of life and keep a woman free from ailments.
"High intake of food items rich in phytoestrogens (flaxseed, sunflower seeds, berries, peanuts, beans and soy) was associated with a monotonically decreasing overall risk [26%] of prostate cancer."
M. Panjehpour, M. Castro, und K. Klotz. Br J Pharmacol, 145 (2):
211-8(Mai 2005)Panjehpour, Mojtaba Castro, Marian Klotz, Karl-Norbert Comparative
Study England British journal of pharmacology Br J Pharmacol. 2005
May;145(2):211-8..